NPI: 1194194720 · LEHIGH ACRES, FL 33936 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 09/24/2015
Authorized official DOAN, CHRISTOPHER controls 20+ related entities in our dataset. Read more
| Authorized Official | DOAN, CHRISTOPHER (CHIEF COMPLIANCE COUNSEL) |
| NPI Enumeration Date | 09/24/2015 |
Other providers sharing the same authorized official: DOAN, CHRISTOPHER
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,381 | $121K |
| 2019 | 38,775 | $522K |
| 2020 | 37,621 | $499K |
| 2021 | 48,983 | $969K |
| 2022 | 45,154 | $1.15M |
| 2023 | 53,751 | $1.38M |
| 2024 | 31,368 | $1.00M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 24,006 | 22,136 | $1.89M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 15,597 | 13,960 | $1.01M |
| 96361 | Intravenous infusion, hydration; each additional hour | 6,031 | 5,040 | $662K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11,226 | 9,676 | $632K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,985 | 1,734 | $313K |
| 70450 | Computed tomography, head or brain; without contrast material | 2,720 | 2,326 | $247K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,113 | 982 | $118K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 7,979 | 6,937 | $94K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,568 | 1,346 | $73K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3,894 | 2,913 | $66K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 316 | 296 | $60K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 623 | 547 | $59K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5,656 | 5,252 | $57K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 808 | 743 | $53K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 16,609 | 8,309 | $46K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 84 | 72 | $22K |
| 72125 | Computed tomography, cervical spine; without contrast material | 436 | 365 | $20K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,801 | 3,303 | $18K |
| 80053 | Comprehensive metabolic panel | 15,502 | 12,930 | $17K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 7,472 | 6,948 | $15K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 63 | 61 | $14K |
| 81003 | 6,365 | 5,570 | $13K | |
| 71045 | Radiologic examination, chest; single view | 6,872 | 5,934 | $12K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 791 | 624 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,350 | 1,175 | $9K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,446 | 1,251 | $8K |
| 81025 | 7,681 | 6,812 | $7K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 123 | 118 | $6K |
| 36415 | Collection of venous blood by venipuncture | 8,912 | 7,430 | $5K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,474 | 1,368 | $5K |
| 81001 | 6,411 | 5,601 | $5K | |
| 73630 | 309 | 266 | $5K | |
| 73562 | 287 | 241 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,393 | 1,206 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,504 | 1,398 | $3K |
| 71046 | Radiologic examination, chest; 2 views | 379 | 354 | $3K |
| 72131 | 95 | 84 | $3K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 615 | 400 | $3K |
| 73610 | 365 | 328 | $3K | |
| 87420 | 268 | 256 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,615 | 4,562 | $2K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 220 | 159 | $2K |
| 82962 | 1,153 | 558 | $2K | |
| 73130 | 215 | 187 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 16,894 | 13,951 | $2K |
| 84484 | 4,747 | 3,450 | $2K | |
| 73030 | 72 | 66 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 5,891 | 4,974 | $2K |
| J7030 | Infusion, normal saline solution , 1000 cc | 8,700 | 7,335 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 654 | 585 | $1K |
| G0378 | Hospital observation service, per hour | 1,246 | 601 | $1K |
| J2704 | Injection, propofol, 10 mg | 1,213 | 599 | $1K |
| 83880 | 1,346 | 1,097 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 4,164 | 3,466 | $1K |
| 87040 | 1,643 | 827 | $994.47 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6,336 | 5,827 | $930.27 |
| 84702 | 830 | 695 | $869.00 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 28 | 24 | $830.25 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,295 | 3,521 | $823.63 |
| 83690 | 7,111 | 6,083 | $782.03 | |
| 73110 | 65 | 59 | $778.92 | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 13 | 12 | $694.42 |
| 85610 | 1,950 | 1,599 | $602.88 | |
| 83605 | 1,120 | 864 | $578.82 | |
| 74018 | 44 | 40 | $547.31 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 1,460 | 1,161 | $528.97 |
| 85379 | 607 | 509 | $508.79 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,034 | 875 | $467.84 |
| 76801 | 152 | 129 | $427.46 | |
| 85730 | 1,405 | 1,158 | $361.86 | |
| 87210 | 56 | 51 | $325.18 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 654 | 585 | $300.30 |
| 96376 | 467 | 342 | $252.51 | |
| 83735 | 831 | 626 | $240.46 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 762 | 588 | $226.69 |
| J2060 | Injection, lorazepam, 2 mg | 134 | 103 | $177.24 |
| 86900 | 246 | 204 | $174.93 | |
| 84443 | Thyroid stimulating hormone (TSH) | 395 | 321 | $171.97 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,365 | 1,085 | $149.60 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,170 | 1,026 | $135.30 |
| 73140 | 13 | 13 | $118.18 | |
| 82550 | 1,050 | 858 | $107.70 | |
| 94760 | 316 | 253 | $103.51 | |
| 80320 | 419 | 366 | $100.44 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 405 | 360 | $92.16 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 692 | 535 | $90.91 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 18 | 15 | $56.83 |
| 94762 | 140 | 121 | $48.31 | |
| 87070 | 1,657 | 1,575 | $29.44 | |
| 85014 | 513 | 480 | $25.74 | |
| 85018 | 513 | 480 | $25.74 | |
| 88312 | 304 | 275 | $7.54 | |
| 86140 | 125 | 106 | $6.61 | |
| 86901 | 230 | 192 | $4.17 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,079 | 990 | $0.08 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 54 | 51 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 281 | 254 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 77 | 55 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 76 | 65 | $0.00 |
| 80061 | Lipid panel | 104 | 85 | $0.00 |
| 90715 | 88 | 76 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 68 | 64 | $0.00 |
| 84145 | 36 | 25 | $0.00 | |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 25 | 25 | $0.00 |
| 94664 | 12 | 12 | $0.00 | |
| 71250 | 17 | 12 | $0.00 | |
| 29125 | 14 | 13 | $0.00 | |
| 72100 | 13 | 13 | $0.00 | |
| 12011 | 12 | 12 | $0.00 | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 14 | 13 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 406 | 369 | $0.00 |
| 85027 | 15 | 12 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 276 | 265 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 136 | 110 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 56 | 39 | $0.00 |
| 80329 | 13 | 12 | $0.00 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 137 | 121 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 101 | 87 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 21 | 13 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 16 | 14 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 19 | 17 | $0.00 |
| J3490 | Unclassified drugs | 24 | 24 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 16 | 16 | $0.00 |